Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

This study examines factors associated with receptive injection equipment sharing among people who inject drugs in the context of COVID-19.

Original research | 2023
About PWUD, Injecting drugs, Harm reduction

Although stigma reduction is a key goal of federal strategies to prevent overdose, there is limited data to assess progress made in reducing use of stigmatizing language about addiction.

Original research | 2023
Stigma

This study examined whether an online training incorporating patient narratives reduced primary care clinicians' (PCCs) stigma toward people with opioid use disorder (primary) and increased intenti

Original research | 2023
About prescribers, Stigma

While daily witnessed opioid agonist treatment (OAT) ingestion is common in British Columbia (BC), Canada, and elsewhere, sparse evidence supports this resource-intensive practice.

Original research | 2023
Policy/Regulatory, Advocacy
Original research | 2023
Policy/Regulatory, Mental health

We developed a survey to assess clinician self-reported barriers, perceptions, and practices for treating HCV-infected patients with SUD and the associations of these barriers, perceptions, and pra

Original research | 2023
About prescribers, Barriers and enablers
Webpage | 2023
Clinical guidance, Harm reduction, About prescribers

We conducted a process evaluation of a novel harm reduction-oriented addiction medicine consultation team [AMCT].

Original research | 2019
Harm reduction, Hospitals
Commentary | 2008
Harm reduction, Equity, Policy/Regulatory

Using our research findings, we explore Harm Reduction and Methadone Maintenance Treatment (MMT) using an intersectional lens to provide a more complex understanding of Harm Reduction and MMT, part

Original research | 2011
Harm reduction, Equity, Mental health, Poverty, Housing, Stigma

Co-use of stimulants and opioids is rapidly increasing.

Original research | 2023
Substitution/OAT, Barriers and enablers, Stimulants, About PWUD

This study aims to explore the experiences of patients receiving depot buprenorphine from an Australian publicly operated drug and alcohol service.

Original research | 2023
Substitution/OAT, About PWUD

PROFAN, a peer-led overdose prevention initiative, was successfully implemented in Montreal, Quebec, for people who use drugs (PWUD), or those likely to witness overdoses.

Original research | 2023
Peer/PWLLE program involvement, Barriers and enablers, Stigma

We sought to compare timely access to methadone treatment in the United States (US) and Canada during the COVID-19 pandemic.

Original research | 2023
Transitions in care/treatment, Substitution/OAT, Policy/Regulatory
Guidelines | 2015
Clinical guidance, About prescribers
Commentary | 2023
Policy/Regulatory, Decriminalization/legalization, Equity

Affiner votre recherche

Mots clés
Format
Région